Developing innovative treatment methods and creating new value
Since its establishment in February 2011, Otsuka Medical Devices Co., Ltd. has focused on developing unique solutions that improve the health and well-being of patients whose medical needs and conditions cannot yet be fulfilled by existing treatment methods. To achieve our aspiration of becoming a pioneer in the medical device industry, we combine global R&D efforts with the technology and drug discovery know-how inherent within the Otsuka group’s heritage.
We will do what it takes to offer patients new innovative treatment choices and stand true to the Otsuka corporate philosophy; “Otsuka—people creating new products for better health worldwide.”
| Company Name | Otsuka Medical Devices Co., Ltd. |
|---|---|
| Established | February 15th, 2011 |
| Capital | 7.55 billion yen |
| Head Office | 2-9, Kanda-Tsukasamachi, Chiyoda-ku, Tokyo 101-0048, Japan |
| Tokyo Headquarters | Shinagawa Grand Central Tower 13F 2-16-4, Konan, Minato-ku, Tokyo 108-0075, Japan [Location] |
| Employees | 99 (As of December 31, 2021) |
| Business Activities | Overseeing medical device operations within the Otsuka group and the business activities of companies engaged in related businesses, as well as all operations incidental to the foregoing activities. |
| Shareholder | Otsuka Holdings Co., Ltd. (100%) |
| President and Representative Director | Noriko Tojo |
|---|---|
| Executive Deputy President | Kazumichi Kobayashi |
| Executive Director | Yoshiro Matsuo |
| Executive Director | Kuniaki Natsume |
| Outside Director | Tomiko Tawaragi |
| Statutory Auditor | Yasuhiro Gomi |
| Outside Audit & Supervisory Board Member | Naoki Miyamori |
(As of March 8, 2022)
JIMRO Co., Ltd.
Biomedical Solutions Inc.
ReCor Medical, Inc.
Veryan Medical Ltd.
Otsuka Medical Devices Europe GmbH
